Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2012
03/08/2012US20120059029 Selective integrin inhibitors
03/08/2012US20120059027 Tacrolimus injection preparation
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059006 Sigma receptor inhibitors
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120059000 Chemical compounds, compositions and methods for kinase modulation
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058979 Methods and reagents for the treatment of immunoinflammatory disorders
03/08/2012US20120058968 Composition containing fermantable polysaccharides
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058963 Macrolides with Anti-Inflammatory Activity
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058936 Compositions and methods for elimination of gram negative bacteria
03/08/2012US20120058206 Antiallergic marine biopolymers
03/08/2012US20120058205 Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
03/08/2012US20120058197 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058162 Stable, spray dryed, immunogenic, viral compositions
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058154 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
03/08/2012US20120058153 Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
03/08/2012US20120058149 Treatment of infection
03/08/2012US20120058148 Certain aminoalkyl glucosaminide phosphate compounds and their use
03/08/2012US20120058147 Geographically Region Specific Allergy Immunotherapy for Companion Animals
03/08/2012US20120058146 Immunogens from uropathogenic escherichia coli
03/08/2012US20120058145 Method for producing virus from cell culture involving homogenization
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058142 Vaccine for protection against shigella sonnei disease
03/08/2012US20120058141 Chimeric newcastle disease viruses and uses thereof
03/08/2012US20120058139 Novel multimodular assembly useful for intracellular delivery
03/08/2012US20120058138 Novel Adenovirus Vectors
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058136 NON-SPLICING VARIANTS OF gp350/220
03/08/2012US20120058134 Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant
03/08/2012US20120058133 Inhibition of trna synthetases and therapeutic applications thereof
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058111 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058096 Compositions and methods for generating interleukin-35-induced regulatory t cells
03/08/2012US20120058093 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
03/08/2012US20120058081 Ex-vivo treatment of peripheral blood leukocytes with IFN-lambda
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012CA2810024A1 Quinazoline compounds and methods of use thereof
03/08/2012CA2809890A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012CA2809837A1 Human immunodeficiency virus (hiv)-neutralizing antibodies
03/08/2012CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same
03/08/2012CA2809112A1 Cyclic amide derivative
03/07/2012EP2426150A1 Anti-NKG2A antibodies and uses thereof
03/07/2012EP2426145A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426144A1 Engineered anti-IL-23p19 antibodies
03/07/2012EP2426129A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2425831A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
03/07/2012EP2424974A1 Mutants of francisella tularensis and uses thereof
03/07/2012EP2424898A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
03/07/2012EP2424864A1 Oxazole substituted indazoles as pi3-kinase inhibitors
03/07/2012EP2424841A1 Pyridinone antagonists of alpha-4 integrins
03/07/2012EP2424560A1 Compounds and methods for modulating an immune response
03/07/2012EP2424537A1 Substituted imidazoquinoxalines
03/07/2012EP2424385A1 A nutritional composition comprising an apple extract and reducing food allergy symptoms, especially in children
03/07/2012EP2424368A1 Pyrrolotriazine compounds
03/07/2012EP1919891B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/07/2012EP1901773B1 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012EP1017353B1 Therapeutic process for inhibiting nf-kappa b
03/07/2012CN202154882U 一种含有纳米辅酶q10颗粒的胶囊 A capsule containing nano-particles of coenzyme q10
03/07/2012CN202154881U 具有增强免疫力功效的茶色素胶囊 With enhanced immunity efficacy tea pigment capsule
03/07/2012CN102369217A Il-1 binding proteins
03/07/2012CN102369200A Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
03/07/2012CN102366607A Traditional Chinese medicine lavipeditum agent for treating allergic rhinitis
03/07/2012CN102366599A Formula and method of traditional Chinese medicine for treating diseases with complication of two tissues of liver meridian and spleen meridian
03/07/2012CN102366518A Method for ultrasonic assisted aqueous two-phase extraction of total dioscin
03/07/2012CN102366398A Multifunctional eye drops
03/07/2012CN102366317A Eye-protection wet tissue
03/07/2012CN101890130B Health wine raw materials and health wine
03/07/2012CN101735306B Anti-inflammatory peptide with membrane penetration effect
03/07/2012CN101676306B Low molecular weight glucan and preparation method and application thereof
03/07/2012CN101664428B Broccoli polyphenol capsules
03/07/2012CN101306115B Decoction for treating acute urticaria
03/07/2012CN101269095B Supercritical combined processing method of ganoderma lucidum and ganoderma lucidum spore
03/07/2012CN101264227B Detection method of 'pingfeng shengmai' capsule
03/07/2012CN101194955B Fumigation medicament for treating eczema
03/07/2012CN101166510B External preparation for skin
03/06/2012US8129541 5-phenylthiazole derivatives and use as PI3 kinase inhibitors
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129507 Atopic dermatitis inducer
03/06/2012US8129408 Pharmaceutical composition for piperidinoalkanol compounds
03/06/2012US8129381 Caspase inhibitors and uses thereof
03/06/2012US8129371 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129167 UL16 binding protein 4
03/06/2012US8129132 Using glutamate decarboxylase concentration as diagnostic indicator of autoimmune and connective tissue disorders
03/06/2012US8128964 Transdermal pharmaceutical delivery composition
03/06/2012CA2487734C Treatment with cytokines for alzheimer's disease
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 1172